: A novel gene fusion in malignant melanoma
Oncogenic gene fusions have been identified in many cancers, and many serve as druggable targets for therapy. Fibroblast growth factor receptor (FGFR) gene aberration is known to be associated with tumor progression and resistance to anticancer therapy. Here we report the first case of malignant mel...
| Autori principali: | , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Sungkyunkwan University School of Medi
2018-06-01
|
| Serie: | Precision and Future Medicine |
| Soggetti: | |
| Accesso online: | http://www.pfmjournal.org/upload/pdf/pfm-2018-00044.pdf |